_______________________________________________________________________ Depression and Suicide
PYFL15DS — 15 CE CREDITS
R elease D ate : 08/01/23
E xpiration D ate : 07/31/26
Depression and Suicide
13. Describe the impact of suicide in the treatment of special populations, including among the elderly. 14. Identify risk and protective factors for suicide. 15. Evaluate tools available for the assessment and evaluation of suicide risk. Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Division Planner Margaret Donohue, PhD Senior Director of Development and Academic Affairs Sarah Campbell Division Planner/Director Disclosure The division planner and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Audience This intermediate course is designed for psychologists in any setting who may identify and treat patients who are depressed and/or suicidal. Course Objective Although contact with the primary care setting represents a potential opportunity for timely identification and intervention, abundant evidence indicates that many patients with depression are inadequately diagnosed and treated in these settings. The purpose of this course is to provide the information and encouragement necessary to allow psychologists to properly diagnose, treat, and follow-up with patients with depression. Learning Objectives Upon completion of this course, you should be able to: 1. Outline the epidemiology of depression and suicide. 2. Identify populations at increased risk for depression. 3. Describe the natural history and patho-physiology of depression. 4. Evaluate the signs and symptoms of depression utilizing appropriate screening tools. 5. Employ the appropriate diagnostic criteria for depression, including modifier subtypes. 6. Assess patients for depressive signs and symptoms, with particular attention to unique features in special populations. 7. Identify other conditions that can mimic or co-occur with depression. 8. Create a treatment plan for patients diagnosed with depression. 9. Compare pharmacotherapies and psychosocial therapies used in the treatment of depression. 10. Assess patients’ reactions to depression treatments and identify treatment-resistance depression. 11. Recognize and appropriately treat perinatal depression. 12. Review the epidemiology of suicide.
Mention of commercial products does not indicate endorsement.
167
EliteLearning.com/Psychology
Powered by FlippingBook